Comparative genomics of BCG vaccines

Authors
Citation
Ma. Behr, Comparative genomics of BCG vaccines, TUBERCULOSI, 81(1-2), 2001, pp. 165-168
Citations number
30
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
TUBERCULOSIS
ISSN journal
14729792 → ACNP
Volume
81
Issue
1-2
Year of publication
2001
Pages
165 - 168
Database
ISI
SICI code
1472-9792(2001)81:1-2<165:CGOBV>2.0.ZU;2-4
Abstract
Bacille Calmette-Guerin (BCG) vaccines have been given to more people than any other vaccine. They have also probably resulted in as much controversy as any other vaccine. In clinical trials, the efficacy of BCG vaccination a gainst pulmonary TB has been widely variable. At the same time, a number of investigators have observed phenotypic differences between BCG daughter st rains, raising the possibility that differences between BCG products may in some way translate into different outcomes. With recent genomic analysis o f BCG strains, it has become possible to piece together the molecular event s that have resulted in current BCG vaccines. Between the derivation of BCG in 1921 and the lyophilization of BCG Pasteur 1173 in 1961,there have been at least seven genetic events, including deletions, duplications and a sin gle nucleotide polymorphism. The phenotypic relevance of these changes in B CG vaccines remains to be explored. (C) 2001 Harcourt Publishers Ltd